Option Care Health, Inc.

Valuation Analysis

About the Company

Option Care Health, Inc. en bref

Option Care Health, Inc. (OPCH) is currently trading at 19,17 € with a market capitalization of 3,0 Md €. The trailing P/E ratio stands at 17.18x, with a forward P/E of 10.73x. The 52-week range spans from 15,70 € to 32,08 €; the current price is 40.2% below the yearly high. Year-over-year revenue growth stands at +1.3%. The net profit margin stands at 3.64%.

💰 Dividende

Option Care Health, Inc. currently does not pay a dividend. The company typically reinvests its earnings into growth initiatives and product development.

📊 Avis des analystes

12 analystes évaluent Option Care Health, Inc. (OPCH) au consensus : Acheter. L'objectif de cours moyen est de 24,92 €, soit un potentiel de +29.98% par rapport au cours actuel. La fourchette des objectifs de cours des analystes va de 19,18 € à 34,00 €.

Option Care Health, Inc. : la thèse d'investissement en détail

Option Care Health, Inc. (OPCH) operates in the Healthcare — specifically Medical Care Facilities — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

Le scénario haussier

Wall Street consensus sits at Buy with an average price target implying roughly 29.98% upside from current levels — analyst sentiment is firmly constructive. Our valuation screen flags the stock as undervalued relative to its fundamentals — multiples are running below where the cash flow profile would normally justify.

Le scénario baissier

Revenue growth has slowed to just 1.3%, which is below nominal GDP — the business is no longer outgrowing the broader economy. With a net margin of just 3.64%, the business has little room to absorb cost shocks or pricing pressure — a single bad quarter can swing the company to a loss. Short interest sits at 10.97% of float — a meaningful contingent of professionals is positioned for the share to fall, which deserves attention even if their thesis may turn out to be wrong.

Valorisation en contexte

The PEG ratio at 1.22 sits in the reasonable zone — the price tag is roughly aligned with the company's growth profile, neither punishing nor euphoric.

À surveiller

• The forward P/E of 10.73x is meaningfully below the trailing 17.18x — analysts expect earnings to step up; the next earnings release is the test.
• The price sits in the lower quartile of the 52-week range — value hunters often start scaling in around this zone if fundamentals hold.
• The analyst consensus price target implies 29.98% upside — if the next two quarters confirm the underlying thesis, target hikes typically follow.

Thèse d'investissement : forces et faiblesses

Aperçu technique

Price is below both the 50- and 200-day moving averages, with 50d below 200d — a bearish picture (death-cross alignment).

Profil de risque

The data points to relatively defensive market behavior, elevated short interest (10.97%).

Trading Data

Related Stocks in the Same Sector

Where can I buy Option Care Health, Inc.?

Compare top-rated brokers — low fees, trusted providers, fully regulated.